Prof. Dr. med. T. F. Schulz Team Team Leader Prof. Dr. med. Thomas F. Schulz Hannover Medical School, MHH Institute of Virology, OE5230 Carl-Neuberg-Str. 1 30625 Hannover GERMANY Phone: +49 511 532 4308 [...] +49 511 532 6736 Laboratory: +49 511 532 4324 FAX: + 49 511 532 8736 Email Schulz.Thomas @ MH-Hannover.de Prof. T.F. Schulz, MD qualified in medicine in 1979 (Mainz University), initially trained in Internal [...] Pietrek M, Viejo-Borbolla A, Schulz TF The ubiquitin-specific protease USP7 modulates the replication of KSHV latent episomal DNA. J. Virol., 2012; 86: 6745-57 Alkharsah KR, Schulz TF. A role for the internal
Center Laboratory Medicine Managing Director: Professor dr. T. Schulz
complement our research areas with their expertise," says RESIST spokesperson Professor Dr Thomas Schulz. These projects are supported Why do some premature babies die from infections? What roles do infections [...] researchers; there are about 50 teams from six institutions. RESIST spokesperson is Professor Dr Thomas Schulz, head of the MHH Institute of Virology. RESIST is funded by the German Research Foundation (DFG)
Javeriana, Bogotá, Colombia Marie Sophie Schulze Research Topic: The herpesviral DNA polymerase-associated factor as a putative drug target Supervisor: Prof. Dr. Thomas Schulz, Institute of Virology, MHH Academic
Julie Sheldon, Twincore Dr. Nora Schmidt, MHH Prof. Dr. Sabrina Schreiner, MHH Prof. Dr. Thomas Schulz, MHH Prof. Dr. Beate Sodeik, MHH Dr. Imke Steffen, TiHo Prof. Dr. Abel Viejo-Borbolla, MHH Prof.
Topic: Identifying new druggable targets in SARS-CoV-2-infected cells Supervisor: Prof. Dr. Thomas Schulz, Institute of Virology, MHH Academic Background: Animal Biology and Biomedical Sciences, TiHo Ilka [...] Topic: Immunomodulation by the Human Cytomegalovirus glycoprotein pUL11 Supervisor: Prof. Dr. Thomas Schulz, Institute of Virology, Hannover Medical School Academic Background: Advanced Virology, University [...] Assembly and its Thymidine Kinase as Potential Antiviral Drug Targets Supervisor: Prof. Dr. Thomas Schulz, Institute of Virology, MHH Academic Background: Medical Microbiology, Tehran University of Medical
increased proliferation of CMML cells from a patient with severe congenital neutropenia. Germeshausen M, Schulze H, Kratz C, Wilkens L, Repp R, Shannon K, Welte K, Ballmaier M. Leukemia. 2005 Apr;19(4):611-7. doi: [...] elastase (ELA2) are not sufficient to cause the phenotype of congenital neutropenia. Germeshausen M, Schulze H, Ballmaier M, Zeidler C, Welte K. Br J Haematol. 2001 Oct;115(1):222-4. doi: 10.1046/j.1365-2141 [...] cytic thrombocytopenia (CAMT) - a defect of the thrombopoietin receptor c-Mpl]. Germeshausen M, Schulze H, Gaudig A, Krukemeier S, Strauss G, Welte K, Ballmaier M. Klin Padiatr. 2001 Jul-Aug;213(4):155-61
Quicklinks: Research Bohne lab Bosse lab Depledge lab Doelken lab Schulz lab Sodeik lab Viejo-Borbolla lab Diagnostic lab / MHH - Central laboratories Address for sample submissions: Med. Hochschule Hannover
an Erasmus Student at The University of Leeds (U.K.). Afterwards, I moved to the lab of Thomas F. Schulz (The University of Liverpool) to do my PhD with the co-supervision of Eddie Blair (GlaxoSmithKline [...] started studying herpesviruses, working first with Kaposi’s sarcoma-associated herpesvirus in Thomas Schulz’s lab at Hannover Medical School and then with herpes simplex virus at Antonio Alcami’s lab at the [...] Waltl, I., Schneider, T., Wachs, A., Ritter, B., Kropp, K.A., Zhu, S., Deleidi, M., Kalinke, U., Schulz, T.F., Höglinger, G., Gerold, G., Wegner, F., and Viejo-Borbolla, A. 2024. Innate immune response
smallest detail. RESIST consists of six partner institutions, the spokesperson is Professor Dr. Thomas Schulz, head of the MHH Institute of Virology. RESIST is funded by the German Research Foundation (DFG)